Genmab | Aktywa



Current Assets Zmiana Data
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Almirall EUR 741.14M 47.91M 2024-12
Amarin USD 650.22M 51.62M 2024-09
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Bayer EUR 34.83B 388M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Demant DKK 9.92B 731M 2024-12
Exelixis USD 1.4B 71.08M 2025-04
Fresenius Medical Care EUR 7.96B 34.93M 2025-03
Galapagos EUR 3.47B 132.9M 2025-03
Genmab DKK 4.04B 23.82B 2025-03
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
GN Store Nord DKK 8.89B 7.82B 2025-03
GRIFOLS EUR 5.64B 87.54M 2025-03
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Insmed USD 1.4B 218.97M 2025-03
Lonza CHF 5.44B 113M 2024-12
Merck EUR 13.45B 479M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
UCB EUR 4.79B 1.47B 2024-12



Genmab Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.